Qilian International Holding Group (BGM) Competitors $7.00 +0.20 (+2.94%) (As of 02:29 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends BGM vs. MGNX, ACRV, XBIT, ENTA, LXRX, ADCT, NKTR, VSTM, DMAC, and NBTXShould you be buying Qilian International Holding Group stock or one of its competitors? The main competitors of Qilian International Holding Group include MacroGenics (MGNX), Acrivon Therapeutics (ACRV), XBiotech (XBIT), Enanta Pharmaceuticals (ENTA), Lexicon Pharmaceuticals (LXRX), ADC Therapeutics (ADCT), Nektar Therapeutics (NKTR), Verastem (VSTM), DiaMedica Therapeutics (DMAC), and Nanobiotix (NBTX). These companies are all part of the "pharmaceutical preparations" industry. Qilian International Holding Group vs. MacroGenics Acrivon Therapeutics XBiotech Enanta Pharmaceuticals Lexicon Pharmaceuticals ADC Therapeutics Nektar Therapeutics Verastem DiaMedica Therapeutics Nanobiotix MacroGenics (NASDAQ:MGNX) and Qilian International Holding Group (NASDAQ:BGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings. Is MGNX or BGM more profitable? Qilian International Holding Group has a net margin of 0.00% compared to MacroGenics' net margin of -69.07%. Qilian International Holding Group's return on equity of 0.00% beat MacroGenics' return on equity.Company Net Margins Return on Equity Return on Assets MacroGenics-69.07% -89.42% -38.57% Qilian International Holding Group N/A N/A N/A Does the MarketBeat Community favor MGNX or BGM? MacroGenics received 426 more outperform votes than Qilian International Holding Group when rated by MarketBeat users. CompanyUnderperformOutperformMacroGenicsOutperform Votes42662.28% Underperform Votes25837.72% Qilian International Holding GroupN/AN/A Do analysts rate MGNX or BGM? MacroGenics presently has a consensus target price of $7.63, indicating a potential upside of 136.80%. Given MacroGenics' stronger consensus rating and higher possible upside, research analysts plainly believe MacroGenics is more favorable than Qilian International Holding Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MacroGenics 0 Sell rating(s) 8 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.36Qilian International Holding Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals hold more shares of MGNX or BGM? 96.9% of MacroGenics shares are held by institutional investors. 11.3% of MacroGenics shares are held by insiders. Comparatively, 58.7% of Qilian International Holding Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has more risk & volatility, MGNX or BGM? MacroGenics has a beta of 2.08, indicating that its stock price is 108% more volatile than the S&P 500. Comparatively, Qilian International Holding Group has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Which has higher earnings and valuation, MGNX or BGM? Qilian International Holding Group has lower revenue, but higher earnings than MacroGenics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMacroGenics$58.75M3.44-$9.06M-$1.58-2.04Qilian International Holding Group$46.47M1.09-$7.78MN/AN/A Does the media refer more to MGNX or BGM? In the previous week, MacroGenics and MacroGenics both had 1 articles in the media. MacroGenics' average media sentiment score of 0.67 beat Qilian International Holding Group's score of 0.00 indicating that MacroGenics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MacroGenics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Qilian International Holding Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMacroGenics beats Qilian International Holding Group on 10 of the 15 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Qilian International Holding Group News Delivered to You Automatically Sign up to receive the latest news and ratings for BGM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGM vs. The Competition Export to ExcelMetricQilian International Holding GroupPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$50.61M$6.53B$5.10B$8.84BDividend YieldN/A8.11%5.04%4.07%P/E RatioN/A5.5095.1214.22Price / Sales1.09375.021,217.3088.42Price / Cash21.5952.5939.4936.27Price / BookN/A10.276.976.37Net Income-$7.78M$153.22M$118.73M$225.56M7 Day Performance9.37%-1.19%-1.22%-0.02%1 Month Performance-9.56%-6.71%-3.07%2.04%1 Year PerformanceN/A32.39%32.52%28.00% Qilian International Holding Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGMQilian International Holding GroupN/A$7.00+2.9%N/AN/A$50.61M$46.47M0.00298Gap UpMGNXMacroGenics3.8787 of 5 stars$3.22-1.8%$7.63+136.8%-57.0%$202.09M$58.75M0.00430ACRVAcrivon Therapeutics2.7542 of 5 stars$6.47-0.5%$23.67+265.8%+62.9%$201.48MN/A0.0058Analyst RevisionXBITXBiotech0.8966 of 5 stars$6.57+1.2%N/A+77.8%$200.25M$4.01M-6.01100Positive NewsENTAEnanta Pharmaceuticals2.9602 of 5 stars$9.26+2.0%$20.00+116.0%+1.6%$196.22M$79.20M-1.67145LXRXLexicon Pharmaceuticals1.9831 of 5 stars$0.79-2.6%$6.00+663.1%-31.6%$193.62M$1.20M0.00285Analyst RevisionADCTADC Therapeutics2.8921 of 5 stars$1.98flat$8.25+316.7%+177.9%$191.45M$69.56M0.00310Positive NewsNKTRNektar Therapeutics4.1024 of 5 stars$1.01+0.5%$3.50+248.3%+92.3%$185.38M$90.12M0.00220VSTMVerastem2.8014 of 5 stars$4.05+6.9%$12.50+208.6%-41.2%$180.27M$2.60M-1.2950Analyst DowngradeAnalyst RevisionNews CoverageDMACDiaMedica Therapeutics1.9115 of 5 stars$4.21+4.7%$7.00+66.3%+62.8%$180.02MN/A0.0020High Trading VolumeNBTXNanobiotix2.3432 of 5 stars$3.80-6.6%$11.50+202.6%-33.5%$179.09M$39.18M0.00100Positive News Related Companies and Tools Related Companies MGNX Competitors ACRV Competitors XBIT Competitors ENTA Competitors LXRX Competitors ADCT Competitors NKTR Competitors VSTM Competitors DMAC Competitors NBTX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BGM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qilian International Holding Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Qilian International Holding Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
